Article info
Original research
Do autoimmune diseases influence the onset and progression of ovarian cancer? A systematic review and meta-analysis
- Correspondence to Dr An Coosemans, Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Leuven 3000, Belgium; an.coosemans{at}kuleuven.be
Citation
Do autoimmune diseases influence the onset and progression of ovarian cancer? A systematic review and meta-analysis
Publication history
- Received March 28, 2022
- Accepted July 18, 2022
- First published August 26, 2022.
Article Versions
- You are currently viewing a Previous version of this article (5 December 2022).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.